91 results
8-K
EX-99.1
PRAX
Praxis Precision Medicines Inc
13 May 24
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Results
8:18am
, combined with a favorable tolerability and safety profile, builds confidence in our planned focal onset seizure studies for PRAX-628, with the first … response.
In the 45 mg cohort (n=3), 100% of patients achieved a complete response.
Safety was consistent with the prior dose escalation study
8-K
EX-1.1
PRAX
Praxis Precision Medicines Inc
29 Mar 24
Other Events
4:30pm
relating to the use, treatment, storage and disposal of hazardous or toxic substances or waste and protection of health and safety or the environment which
424B5
PRAX
Praxis Precision Medicines Inc
29 Mar 24
Prospectus supplement for primary offering
4:29pm
of generalized
S-1
PPR events at any assessment period versus baseline. Safety results were consistent with our prior Phase 1 dose escalation study
424B5
zownhgw
27 Mar 24
Prospectus supplement for primary offering
4:49pm
8-K
xikm rnkj
26 Mar 24
Other Events
7:01am
S-3
EX-1.2
73tmem26ew3oam37e
5 Mar 24
Shelf registration
9:08am
8-K
EX-99.1
duxlku6z2ads1dv y7g
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
8-K
EX-99.2
m49g9cai 3x7brv3ug
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
8-K
EX-1.1
v2bep l58p
12 Jan 24
Other Events
5:23pm
8-K
EX-1.1
sjdl1xgxzi
7 Dec 23
Entry into a Material Definitive Agreement
5:23pm
8-K
EX-99.1
76eg4pgg2c9kp0 yc
7 Nov 23
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2023 Financial Results
7:35am
8-K
qr3mflgu 5r7
2 Oct 23
Other Events
1:27pm
8-K
fs6vxuu6 8ivwl4l
9 Aug 23
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial Results
8:27am
8-K
EX-99.1
lu8rjkgdky
9 Aug 23
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial Results
8:27am
8-K
EX-99.2
w36jixoyx1nnyw 18wfm
9 Aug 23
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial Results
8:27am